Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15974253 | 1.00 | CA12 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17331188 | 0.96 | CA12 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15973974 | 0.96 | CA12 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17344065 | 0.93 | TTR (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17344062 | 0.90 | TTR (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18098004 | 0.83 | P4HB (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16749652 | 0.82 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11332365 | 0.81 | CA12 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1133144 | 0.81 | CA12 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13297245 | 0.81 | CA12 (0.53) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9539559-B2 | Metal-organic frameworks for selective separations | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-01-10 | — | — | US | disclosed |
| US-20150360201-A1 | METAL-ORGANIC FRAMEWORKS FOR SELECTIVE SEPARATIONS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-12-17 | — | — | US | disclosed |
| WO-2014130246-A1 | METAL-ORGANIC FRAMEWORKS FOR SELECTIVE SEPARATIONS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150360201-A1 | METAL-ORGANIC FRAMEWORKS FOR SELECTIVE SEPARATIONS | OR10J3, MRPS22, MRPS23 | CA12 24/4885CA1 297/4885CA2 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.